617 filings
Page 2 of 31
8-K
0xcg7smq5n4
28 Feb 23
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2022 Financial Results
7:33am
8-K
ijel96o
28 Dec 22
U.S. Commercial launch expected Q1 2023
4:30pm
8-K
6elyzqy
10 Nov 22
TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
7:38am
S-3ASR
gzryldf
2 Sep 22
Automatic shelf registration
4:31pm
8-K
gbdpr1616ovuwz50be35
8 Aug 22
TG Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
7:37am
S-8
g0d6egr2
24 Jun 22
Registration of securities for employees
5:10pm
8-K
t28uo ikdf
23 Jun 22
Submission of Matters to a Vote of Security Holders
4:31pm
DEFA14A
f0idl
29 Apr 22
Additional proxy soliciting materials
12:00am
8-K
969xebb3
18 Apr 22
TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
7:30am
8-K
px4ss8ikthmgg8vs 30
1 Mar 22
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2021 Financial Results
8:15am
8-K
f57jf zzhy0
27 Jan 22
Other Events
10:01am
8-K
h0u50dz
4 Jan 22
Entry into a Material Definitive Agreement
7:39am
8-K
lg3r3kuo
30 Nov 21
TG Therapeutics Provides Regulatory Update
7:59am
8-K
g34h4f od
4 Nov 21
TG Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
7:27am